EPS for Burcon NutraScience (BU) Expected At $0.00; Houlihan Lokey (HLI) Sellers Decreased By 23.28% Their Shorts

May 22, 2017 - By Clifton Ray

Houlihan Lokey Incorporated (NYSE:HLI) had a decrease of 23.28% in short interest. HLI’s SI was 290,400 shares in May as released by FINRA. Its down 23.28% from 378,500 shares previously. With 171,500 avg volume, 2 days are for Houlihan Lokey Incorporated (NYSE:HLI)’s short sellers to cover HLI’s short positions. The SI to Houlihan Lokey Incorporated’s float is 4.15%. The stock increased 0.03% or $0.01 on May 19, reaching $34.12. About shares traded. Houlihan Lokey Inc (NYSE:HLI) has risen 6.00% since April 22, 2017 and is uptrending. It has by 0.00% the S&P500.

Analysts expect Burcon NutraScience Corp (TSE:BU) to report $0.00 EPS on June, 26. It closed at $1.4 lastly. It is up 6.00% since April 22, 2017 and is uptrending. It has by 0.00% the S&P500.

Among 5 analysts covering Houlihan Lokey (NYSE:HLI), 2 have Buy rating, 0 Sell and 3 Hold. Therefore 40% are positive. Houlihan Lokey had 9 analyst reports since September 8, 2015 according to SRatingsIntel. The stock has “Buy” rating by Bank of America on Tuesday, September 8. The rating was initiated by JMP Securities on Tuesday, September 8 with “Mkt Outperform”. The firm has “Outperform” rating given on Tuesday, September 8 by Keefe Bruyette & Woods. The firm has “Neutral” rating given on Thursday, May 11 by Bank of America. Sandler O’Neill downgraded the stock to “Hold” rating in Thursday, August 18 report. Sandler O’Neill initiated Houlihan Lokey Inc (NYSE:HLI) on Tuesday, September 8 with “Buy” rating. The stock of Houlihan Lokey Inc (NYSE:HLI) has “Neutral” rating given on Tuesday, September 8 by Goldman Sachs.

Houlihan Lokey, Inc. is a global independent investment bank that focuses on mergers and acquisitions , financings, financial restructurings and financial advisory services. The company has market cap of $2.30 billion. The Firm operates through three divisions: Corporate Finance, Financial Restructuring and Financial Advisory Services. It has a 20.97 P/E ratio. The Firm serves a set of clients across the world, including firms, financial sponsors and government agencies.

Burcon NutraScience Corp is a Canada company, which is engaged in development of functional and renewable plant proteins. The company has market cap of $52.96 million. The Firm has developed a portfolio of composition, application and process patents originating from a core protein extraction and purification technology. It currently has negative earnings. The Firm and its subsidiary have developed CLARISOY, a soy protein; and are developing Peazazz, a pea protein, and Puratein, Supertein and Nutratein, approximately three canola protein isolates.